While celebrities like Michael J. Fox and Brett Favre have been open about their struggles with Parkinson's disease, it can ...

Treatment with an oral allosteric modulator was nonsuperior to placebo at 6 weeks in adults with Parkinson’s disease whose ...

Grifols, a global healthcare company and leading producer of plasma-derived medicines, today announced it has received a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to ...

In the past, Parkinson’s disease was primarily considered a disorder of the nervous system, centered in the brain. However, ...

A 47-year-old man was the first in the world to be treated outside of a study context with a new technique for the symptoms ...

Learn how caffeine affects Parkinson's disease prevention and treatment. New research uncovers both protective benefits and treatment limitations.

The Michael J. Fox Foundation for Parkinson’s Research has partnered with Grifols, a global healthcare company, to identify ...

Parkinson's disease is a solvable problem, but only if we act decisively and urgently. We have the knowledge, and we've built ...

Growing older is the greatest risk factor for acquiring Parkinson’s disease and many people live with symptoms for several years before being diagnosed. Often people in early stages of Parkinson’s ...

Women's risk of Parkinson's is similar to men's - but they are much more likely to be misdiagnosed, with serious consequences ...

Early signs of Parkinson's disease may manifest as subtle vocal changes, such as a soft or monotonous voice, decades before typical movement symptoms. Research on songbirds suggests these vocal ...

Andrew Cassy had spent his working life in a telecommunications research department until a diagnosis of Parkinson’s disease ... understanding the disease and finding good treatments,” he ...